TCT 2019: TRILUMINATE Six-Month Results Support Abbott’s TriClip

 
• By Reed Miller

The six-month results of the TRILUMINATE Feasibility trial support the safety and effectiveness of Abbott’s TriClip, a version of the company’s successful MitraClip adapted to repair the tricuspid valve. The company is now sponsoring a pivotal trial to support FDA approval of TriClip.

Beautiful view of business center in downtown San Francisco in USA at dusk. - Image
• Source: shutterstock.com

More from Clinical Trials

More from R&D